Abituzumab
- Generic Name
- Abituzumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1105038-73-0
- Unique Ingredient Identifier
- 724QD330RD
- Background
Abituzumab has been used in trials studying the treatment of Prostate Cancer Metastatic.
- Associated Conditions
- -
- Associated Therapies
- -
Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment
Integrin αvβ6 plays a crucial role in cell adhesion, migration, and signaling, with significant implications in cancer progression and epithelial-mesenchymal transition (EMT). Its up-regulation is linked to poor prognosis in various cancers, making it a potential target for cancer treatment. Research focuses on its biology, role in healthy humans, and therapeutic targeting strategies, including imaging and drug delivery approaches.
Related Clinical Trials:
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath